599 related articles for article (PubMed ID: 12555013)
21. Unresolved issues about post-ERCP pancreatitis: an overview.
Testoni PA
JOP; 2002 Nov; 3(6):156-61. PubMed ID: 12432181
[TBL] [Abstract][Full Text] [Related]
22. Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: results, techniques, and indications.
Tarnasky PR
JOP; 2003 Jan; 4(1):58-67. PubMed ID: 12555017
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.
Masci E; Mariani A; Curioni S; Testoni PA
Endoscopy; 2003 Oct; 35(10):830-4. PubMed ID: 14551860
[TBL] [Abstract][Full Text] [Related]
24. Indomethacin for post-ERCP pancreatitis prophylaxis: another attempt at the Holy Grail.
Wagh MS; Sherman S
Am J Gastroenterol; 2007 May; 102(5):984-6. PubMed ID: 17489783
[TBL] [Abstract][Full Text] [Related]
25. Post-ERCP pancreatitis and its prevention.
Frank CD; Adler DG
Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):680-8. PubMed ID: 17130878
[TBL] [Abstract][Full Text] [Related]
26. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
[TBL] [Abstract][Full Text] [Related]
27. Difficult biliary cannulation during ERCP: how to facilitate biliary access and minimize the risk of post-ERCP pancreatitis.
Testoni PA; Testoni S; Giussani A
Dig Liver Dis; 2011 Aug; 43(8):596-603. PubMed ID: 21377432
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic pancreatic endoscopy.
Neuhaus H
Endoscopy; 2004 Jan; 36(1):8-16. PubMed ID: 14722850
[TBL] [Abstract][Full Text] [Related]
29. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M
Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467
[TBL] [Abstract][Full Text] [Related]
30. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis.
Kaffes AJ; Bourke MJ; Ding S; Alrubaie A; Kwan V; Williams SJ
Gastrointest Endosc; 2006 Sep; 64(3):351-7. PubMed ID: 16923481
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
Sherman S; Alazmi WM; Lehman GA; Geenen JE; Chuttani R; Kozarek RA; Welch WD; Souza S; Pribble J;
Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):462-72. PubMed ID: 19231487
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.
Sherman S; Cheng CL; Costamagna G; Binmoeller KF; Puespoek A; Aithal GP; Kozarek RA; Chen YK; Van Steenbergen W; Tenner S; Freeman M; Monroe P; Geffner M; Deviere J;
Pancreas; 2009 Apr; 38(3):267-74. PubMed ID: 19214137
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Pande H; Thuluvath P
Drugs; 2003; 63(17):1799-812. PubMed ID: 12921486
[TBL] [Abstract][Full Text] [Related]
34. Guidewire cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation.
Artifon EL; Sakai P; Cunha JE; Halwan B; Ishioka S; Kumar A
Am J Gastroenterol; 2007 Oct; 102(10):2147-53. PubMed ID: 17581267
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for pancreatitis after pancreatic sphincterotomy: a review of 572 cases.
Hookey LC; RioTinto R; Delhaye M; Baize M; Le Moine O; Devière J
Endoscopy; 2006 Jul; 38(7):670-6. PubMed ID: 16810591
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin injection after biliary sphincterotomy.
Gorelick A; Barnett J; Chey W; Anderson M; Elta G
Endoscopy; 2004 Feb; 36(2):170-3. PubMed ID: 14765315
[TBL] [Abstract][Full Text] [Related]
37. Adverse outcomes of endoscopic retrograde cholangiopancreatography.
Freeman ML
Rev Gastroenterol Disord; 2002; 2(4):147-68. PubMed ID: 12481167
[TBL] [Abstract][Full Text] [Related]
38. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.
Fogel EL; Eversman D; Jamidar P; Sherman S; Lehman GA
Endoscopy; 2002 Apr; 34(4):280-5. PubMed ID: 11932782
[TBL] [Abstract][Full Text] [Related]
39. Frequency of common factors for post endoscopic retrograde cholangiopancreatography pancreatitis.
Haqqi SA; Mansoor-ul-Haq M; Shaikh H
J Coll Physicians Surg Pak; 2011 Aug; 21(8):464-7. PubMed ID: 21798131
[TBL] [Abstract][Full Text] [Related]
40. MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes.
Testoni PA; Mariani A; Curioni S; Zanello A; Masci E
Gastrointest Endosc; 2008 Jun; 67(7):1028-34. PubMed ID: 18179795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
